GH - Guardant Health Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 AAPL (%) UGAZ (%) VXX (%) BABA (0%) DFFN (%) NVDA (0%) SPY (%) MARA (0%) MA (0%) JNPR (%) JNCE (0%) JAKK (%) ISRG (0%) IPI (0%) HD (0%) GOOGL (%) GME (0%) EXPR (0%) ETSY (0%) EOSUSD (%) DPW (0%) DCPH (%) CGIX (0%) BNGO (0%) BBBY (%)

Spero Posts Preliminary Data on SPR720 f...	12/05/19
Spero (SPRO) reports preliminary findings from a phase I first-in-human study on SPR720, presently being evaluated for the treatment of nontuberculous...

Is Guardant Health (GH) Stock Outpacing ...	12/03/19
Is (GH) Outperforming Other Medical Stocks This Year?

Top Ranked Momentum Stocks to Buy for De...	12/02/19
Top Ranked Momentum Stocks to Buy for December 2nd

Zacks.com featured highlights include: K...	12/02/19
Zacks.com featured highlights include: Kirkland Lake Gold, Target and Guardant Health

Top 3 Momentum Anomaly Stocks to Buy for...	11/29/19
These stocks are currently witnessing short-term pullback in a bull market. So, this could just be the perfect entry point for investors who are looki...

Alkermes to Acquire Rodin Therapeutics, ...	11/19/19
Alkermes (ALKS) will acquire Rodin Therapeutics for an upfront cash payment of $100 million and up to $850 million in milestone payments.

Guardant Health Shares March Higher, Can...	11/19/19
As of late, it has definitely been a great time to be an investor Guardant Health.

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Service Name	Trader	% Success
High Growth Stocks- Long only	Srini Donapati	68.00 %	Follow

Service Name

Trader

% Success

High Growth Stocks- Long only

Srini Donapati

68.00 %

Previous Close	$73.58	Open
Volume	20	Market Cap	6.755B
Yield		Last Dividend

Date	2019-11-07 (AMC)	Est. (EPS/Rev.)	($0.37)/ 45.42M
Actual (EPS/Rev.)	$-0.14/ $60.85 M	EPS (TTM)	0

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

GH - Guardant Health

$73.58 0[%]

Add to New List:

Day

52 Week

ANALYST RATINGS

100.00 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $GH

About Us

Product Types

Strategies

Follow Us

Secure Payments

Buy rating	08/07/19
Canaccord Genuity maintains Buy rating and raises Price Target from $96.00 to $125.00